Dr. Daniel Cameron

by Daniel J. Cameron, MD MPH A 51-year-old man in the United Kingdom was hospitalized with retrosternal, dull chest pain. He had a history of palpitations, dizziness, and sweating and a previous transient ischemic attack.[1] He presented with a heart rate of 180 with right bundle branch block, a superior QRS axis, and signs of […]

by Daniel J. Cameron, MD MPH According to a 2017 study published in Clinical Infectious Disease, a pronounced TH17 cytokine response may be beneficial in the early stages of Lyme disease. “In these patients, the levels of inflammatory mediators, particularly TH17-associated cytokines, correlated directly with B. burgdorferi IgG antibodies (P<0.02), suggesting a beneficial role for

Questing ticks were collected from grassland, hedges, parks, woodland and woodland edges in Salisbury, an urban area located in Wiltshire, England. Ticks were identified at over 50% of the 25 sites surveyed. Furthermore, investigators reported that the collected ticks carried two pathogens posing a health risk to the public. The “DNA of Borrelia burgdorferi s.l.

by Daniel J. Cameron, MD MPH In a review, published in Cochrane, entitled Antibiotics for the neurological complications of Lyme disease, Cadavid and colleagues identify several trials investigating the effectiveness of antibiotic treatments for neurological Lyme disease in Europe. The authors describe generally favorable outcomes for treating neurologic complications of Lyme disease. “The majority of people

by Daniel J. Cameron, MD MPH Older hybrid Ixodes scapularis ticks did not do so well. “Four month old larvae resulting from a cross between Wisconsin males and South Carolina females died faster under southern than under northern conditions in the lab,” explains Ginsberg. But then again, it is unlikely that an individual would be

by Daniel J. Cameron, MD MPH The findings of this double-blinded placebo controlled clinical trial were published in The Lancet Infectious Disease. In a post hoc analysis of 134 subjects, the authors were able to prevent 6 rashes if the gel was applied after a tick bite. The gel delayed the onset of EM rashes

by Daniel J. Cameron, MD MPH The Centers for Disease Control and Prevention (CDC) have been charged with identifying counties endemic for Lyme disease (LD). But how accurate is the information provided to the public? As of 2016, 50% of the counties in the USA have been designated as endemic for the disease. [2] “The

by Daniel J. Cameron, MD MPH 1. Growing list of eye problems in Lyme disease Ophthalmic manifestations of tick-borne diseases are increasing. And, “although ocular involvement can be self-limited, delays in diagnosis may result in vision impairment and even blindness,” stated Sathiamoorthi from the Mayo Clinic. 2. Study raises concerns for Babesia patients and blood banks Babesiosis, an

Questing black-legged ticks (I. scapularis) associated with Lyme disease (LD) were collected at several locations on the Outer Banks of North Carolina between 1991 and 2009.  The authors found that in October 1991, Borrelia burgdorferi-infected I. scapularis ticks were detected at 50% of the sites (four of the eight). “The spirochetes were consistently detected in

by Daniel J. Cameron, MD MPH “Knowledge of systemic and ophthalmic manifestations combined with an understanding of the epidemiology of disease vectors is crucial for the diagnosis of tick-borne diseases,” she explains. While manifestations may be present with LD and Rocky Mountain spotted fever, ocular involvement is rare in other tick-borne diseases such as babesiosis,